Recent Circulars
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trading in Rights Entitlements (REs) for renunciation of VIRAM SUVARN LIMITED permitted from January 23, 2026 to January 30, 2026, with … | |||||||||||||||
Trading in Rights Entitlements (REs) for renunciation of VIRAM SUVARN LIMITED permitted from January 23, 2026 to January 30, 2026, with Rights Issue opening from January 23, 2026 to February 06, 2026.
| |||||||||||||||
Trading of Rights Entitlements (REs) for renunciation of VIRAM SUVARN LIMITED permitted on BSE from January 23, 2026 to January 30, 2026, … | |||||||||||||||
Trading of Rights Entitlements (REs) for renunciation of VIRAM SUVARN LIMITED permitted on BSE from January 23, 2026 to January 30, 2026, with Rights Issue opening January 23, 2026 to February 06, 2026.
| |||||||||||||||
BSE announces commencement of trading in Rights Entitlements (REs) for VIRAM SUVARN LIMITED from January 23, 2026 to January 30, 2026, with … | |||||||||||||||
BSE announces commencement of trading in Rights Entitlements (REs) for VIRAM SUVARN LIMITED from January 23, 2026 to January 30, 2026, with rights issue opening from January 23 to February 06, 2026.
| |||||||||||||||
DR Lalchandani Labs Limited has announced a 1:1 rights issue of equity shares at par value of Rs. 10 per share, with record date on January … | |||||||||||||||
DR Lalchandani Labs Limited has announced a 1:1 rights issue of equity shares at par value of Rs. 10 per share, with record date on January 27, 2026.
| |||||||||||||||
DR LALCHANDANI LABS LIMITED announces 1:1 rights issue at par value of Rs.10 per share with record date on January 27, 2026. | |||||||||||||||
DR LALCHANDANI LABS LIMITED announces 1:1 rights issue at par value of Rs.10 per share with record date on January 27, 2026.
| |||||||||||||||
Consolidated regulations governing the issue and listing of non-convertible securities including debt securities and non-convertible … | |||||||||||||||
Consolidated regulations governing the issue and listing of non-convertible securities including debt securities and non-convertible redeemable preference shares, with amendments effective as of January 21, 2026.
| |||||||||||||||
BSE updates the list of securities under Short Term ASM framework effective January 22, 2026, including new additions, stage movements, and … | |||||||||||||||
BSE updates the list of securities under Short Term ASM framework effective January 22, 2026, including new additions, stage movements, and securities moving out of the framework.
| |||||||||||||||
Titan Biotech Ltd has announced a 1:5 stock split, subdividing each equity share of Rs.10/- face value into five equity shares of Rs.2/- … | |||||||||||||||
Titan Biotech Ltd has announced a 1:5 stock split, subdividing each equity share of Rs.10/- face value into five equity shares of Rs.2/- face value, effective February 20, 2026.
| |||||||||||||||
Titan Biotech Ltd announces sub-division of equity shares from Rs.10/- each into five equity shares of Rs.2/- each, with record date of … | |||||||||||||||
Titan Biotech Ltd announces sub-division of equity shares from Rs.10/- each into five equity shares of Rs.2/- each, with record date of February 20, 2026.
| |||||||||||||||
Trading suspended for ADITYA BIRLA CAPITAL LTD debentures (ABCL-7.88%-12-2-26-PVT) from January 28, 2026 due to redemption and interest … | |||||||||||||||
Trading suspended for ADITYA BIRLA CAPITAL LTD debentures (ABCL-7.88%-12-2-26-PVT) from January 28, 2026 due to redemption and interest payment with record date January 28, 2026.
| |||||||||||||||